Financial News
All News about Arrowhead Pharma
![](https://mms.businesswire.com/media/20220510006259/en/523535/5/ah_logo_cmyk.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/05/10/analysis-gea8109339_1920.jpg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20220509005369/en/1447505/5/Picture2.jpg)
![](https://mms.businesswire.com/media/20220502005333/en/523535/5/ah_logo_cmyk.jpg)
![](https://mms.businesswire.com/media/20220502005289/en/523535/5/ah_logo_cmyk.jpg)
![](https://cdn.pixabay.com/photo/2018/07/15/10/44/dna-3539309_960_720.jpg)
Via Talk Markets
![](https://mms.businesswire.com/media/20220427005098/en/523535/5/ah_logo_cmyk.jpg)
Arrowhead Pharmaceuticals to Host Pulmonary R&D Day
April 27, 2022
Via Business Wire
![](https://mms.businesswire.com/media/20220426005404/en/523535/5/ah_logo_cmyk.jpg)
![](https://mms.businesswire.com/media/20220425005291/en/523535/5/ah_logo_cmyk.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/04/24/biotech2.jpg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://mms.businesswire.com/media/20220420005909/en/523535/5/ah_logo_cmyk.jpg)
![](https://mms.businesswire.com/media/20220406005336/en/523535/5/ah_logo_cmyk.jpg)
![](https://mms.businesswire.com/media/20220401005135/en/523535/5/ah_logo_cmyk.jpg)
![](https://mms.businesswire.com/media/20220324005293/en/523535/5/ah_logo_cmyk.jpg)
![](https://mms.businesswire.com/media/20220315005352/en/523535/5/ah_logo_cmyk.jpg)
![](https://mms.businesswire.com/media/20220224005435/en/523535/5/ah_logo_cmyk.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/options_image_464.jpeg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20220221005057/en/779279/5/Screen_Shot_2020-03-10_at_10.22.21_AM.jpg)
![](https://mms.businesswire.com/media/20220218005420/en/779279/5/Screen_Shot_2020-03-10_at_10.22.21_AM.jpg)
![](https://mms.businesswire.com/media/20220218005072/en/523535/5/ah_logo_cmyk.jpg)
![](https://mms.businesswire.com/media/20220217005207/en/1362803/5/ah_logo_cmyk.jpg)
Arrowhead Presents New Clinical Data on ARO-HIF2 at ASCO GU 2022
February 17, 2022
Via Business Wire
![](https://investorplace.com/wp-content/uploads/2019/07/stocks-to-buy-2.jpg)
![](https://cdn.benzinga.com/files/images/story/2022/roce_image_88.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2012/test-gcd00d1810_1280.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_683.jpeg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20220202005863/en/523535/5/ah_logo_cmyk.jpg)
Arrowhead Pharmaceuticals Reports Fiscal 2022 First Quarter Results
February 02, 2022
Via Business Wire
![](https://cdn.benzinga.com/files/images/story/2012/medicine-1309148_1920_405.jpg?width=1200&height=800&fit=crop)
![](/images/schema-image-default.png)
![](https://cdn.benzinga.com/files/images/story/2022/earnings_image_603.jpeg?width=1200&height=800&fit=crop)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.